Updated Jul 16, 2026
Donley Matthew Maxwell is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Matthew Maxwell Donley is a corporate executive currently serving as the Chief Operating Officer at Aurinia Pharmaceuticals Inc. He has a background in pharmaceutical operations and management, contributing to the company's strategic initiatives and operational efficiency.
| Role | Chief Operating Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | F — Tax withholding / forfeiture | 40.8K | $14.21 | $579K |
| 2026-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | A — Grant or award | 58.2K | $0.00 | |
| 2026-02-23 | AUPH | Aurinia Pharmaceuticals Inc. | F — Tax withholding / forfeiture | 32.9K | $14.40 | $474K |
Matthew Maxwell Donley is a corporate executive currently serving as the Chief Operating Officer at Aurinia Pharmaceuticals Inc. He has a background in pharmaceutical operations and management, contributing to the company's strategic initiatives and operational efficiency.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Donley Matthew Maxwell profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.